Ngā hua rapu - Penninx, B W J H
- E whakaatu ana i te 1 - 20 hua o te 31
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
-
4
-
5
-
6
Pathophysiology of major depressive disorder: mechanisms involved in etiology are not associated with clinical progression mā Verduijn, J, Milaneschi, Y, Schoevers, R A, van Hemert, A M, Beekman, A T F, Penninx, B W J H
I whakaputaina 2015Text -
7
-
8
-
9
Oxidative stress, anti-oxidants and the cross-sectional and longitudinal association with depressive symptoms: results from the CARDIA study mā Black, C N, Penninx, B W J H, Bot, M, Odegaard, A O, Gross, M D, Matthews, K A, Jacobs, D R
I whakaputaina 2016Text -
10
-
11
The association between immune activation and manic symptoms in patients with a depressive disorder mā Becking, K, Boschloo, L, Vogelzangs, N, Haarman, B C M, Riemersma-van der Lek, R, Penninx, B W J H, Schoevers, R A
I whakaputaina 2013Text -
12
The similarity of the structure of DSM-IV criteria for major depression in depressed women from China, the United States and Europe mā Kendler, K. S., Aggen, S. H., Li, Y., Lewis, C. M., Breen, G., Boomsma, D. I., Bot, M., Penninx, B. W. J. H., Flint, J.
I whakaputaina 2015Text -
13
Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatment mā Molendijk, M L, Bus, B A A, Spinhoven, Ph, Penninx, B W J H, Kenis, G, Prickaerts, J, Voshaar, RC Oude, Elzinga, B M
I whakaputaina 2011Text -
14
Association of depressive disorders, depression characteristics and antidepressant medication with inflammation mā Vogelzangs, N, Duivis, H E, Beekman, A T F, Kluft, C, Neuteboom, J, Hoogendijk, W, Smit, J H, de Jonge, P, Penninx, B W J H
I whakaputaina 2012Text -
15
-
16
BDNF val(66)met affects hippocampal volume and emotion-related hippocampal memory activity mā Molendijk, M L, van Tol, M-J, Penninx, B W J H, van der Wee, N J A, Aleman, A, Veltman, D J, Spinhoven, P, Elzinga, B M
I whakaputaina 2012Text -
17
Affect fluctuations examined with ecological momentary assessment in patients with current or remitted depression and anxiety disorders mā Schoevers, R. A., van Borkulo, C. D., Lamers, F., Servaas, M.N., Bastiaansen, J. A., Beekman, A. T. F., van Hemert, A. M., Smit, J. H., Penninx, B. W. J. H., Riese, H.
I whakaputaina 2021Text -
18
Prognostic significance of social network, social support and loneliness for course of major depressive disorder in adulthood and old age mā van den Brink, R. H. S., Schutter, N., Hanssen, D. J. C., Elzinga, B. M., Rabeling-Keus, I. M., Stek, M. L., Comijs, H. C., Penninx, B. W. J. H., Oude Voshaar, R. C.
I whakaputaina 2017Text -
19
Fatty acids and recurrence of major depressive disorder: combined analysis of two Dutch clinical cohorts mā Thesing, C. S., Lok, A., Milaneschi, Y., Assies, J., Bockting, C. L. H., Figueroa, C. A., Giltay, E. J., Penninx, B. W. J. H., Ruhé, H. G., Schene, A. H., Bot, M., Mocking, R. J. T.
I whakaputaina 2019Text -
20
Decreased functional connectivity of the insula within the salience network as an indicator for prospective insufficient response to antidepressants mā Geugies, H., Opmeer, E.M., Marsman, J.B.C., Figueroa, C.A., van Tol, M.J., Schmaal, L., van der Wee, N.J.A., Aleman, A., Penninx, B.W.J.H., Veltman, D.J., Schoevers, R.A., Ruhé, H.G.
I whakaputaina 2019Text